168 related articles for article (PubMed ID: 35513366)
61. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
62. Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer.
Li Z; Ding Z; Rong D; Tang W; Cao H
Oncol Lett; 2019 Sep; 18(3):3211-3217. PubMed ID: 31452798
[TBL] [Abstract][Full Text] [Related]
63. lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway.
Zhang Q; Li T; Wang Z; Kuang X; Shao N; Lin Y
J Cell Mol Med; 2020 Jul; 24(14):8236-8247. PubMed ID: 32548873
[TBL] [Abstract][Full Text] [Related]
64. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.
Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J
Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997
[TBL] [Abstract][Full Text] [Related]
65. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
[TBL] [Abstract][Full Text] [Related]
66. Long Non-coding RNA JHDM1D-AS1 Interacts with DHX15 Protein to Enhance Non-Small-Cell Lung Cancer Growth and Metastasis.
Yao G; Chen K; Qin Y; Niu Y; Zhang X; Xu S; Zhang C; Feng M; Wang K
Mol Ther Nucleic Acids; 2019 Dec; 18():831-840. PubMed ID: 31739208
[TBL] [Abstract][Full Text] [Related]
67. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
[TBL] [Abstract][Full Text] [Related]
68. Screening of a Novel Upregulated lncRNA, A2M-AS1, That Promotes Invasion and Migration and Signifies Poor Prognosis in Breast Cancer.
Fang K; Caixia H; Xiufen Z; Zijian G; Li L
Biomed Res Int; 2020; 2020():9747826. PubMed ID: 32352014
[TBL] [Abstract][Full Text] [Related]
69. Long Non-coding RNA RUNDC3A-AS1 Promotes Lung Metastasis of Thyroid Cancer via Targeting the miR-182-5p/ADAM9.
Ma D; Zhu Y; Zhang X; Zhang J; Chen W; Chen X; Qian Y; Zhao Y; Hu T; Yao Z; Zhao W; Zhang Y; Liu F
Front Cell Dev Biol; 2021; 9():650004. PubMed ID: 34046406
[TBL] [Abstract][Full Text] [Related]
70. A high level of the long non-coding RNA
She Q; Chen Y; Liu H; Tan J; Li Y
Bioengineered; 2022 May; 13(5):13437-13451. PubMed ID: 36700469
[TBL] [Abstract][Full Text] [Related]
71. Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity.
Dong HT; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Wu Y; Zheng X; Jin F; Li J; Xing P
Mol Ther Nucleic Acids; 2020 Mar; 19():696-705. PubMed ID: 31945728
[TBL] [Abstract][Full Text] [Related]
72. Long non-coding RNA AFAP1-antisense RNA 1 promotes the proliferation, migration and invasion of gastric cancer cells and is associated with poor patient survival.
Zhao H; Zhang K; Wang T; Cui J; Xi H; Wang Y; Song Y; Zhao X; Wei B; Chen L
Oncol Lett; 2018 Jun; 15(6):8620-8626. PubMed ID: 29805596
[TBL] [Abstract][Full Text] [Related]
73. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
Zhang G; An X; Zhao H; Zhang Q; Zhao H
Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
[TBL] [Abstract][Full Text] [Related]
74. Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
Liu XB; Han C; Sun CZ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):110-117. PubMed ID: 29364477
[TBL] [Abstract][Full Text] [Related]
75. lncRNA USP2-AS1 promotes colon cancer progression by modulating Hippo/YAP1 signaling.
Li D; Bao J; Yao J; Li J
Am J Transl Res; 2020; 12(9):5670-5682. PubMed ID: 33042447
[TBL] [Abstract][Full Text] [Related]
76. LncRNA TRHDE-AS1 and MiR-1275 as Promising Prognostic Biomarkers and Effects on Tumor Cell Progression in Gastric Cancer.
Liu F; Cui J; Xue D
Tohoku J Exp Med; 2023 Sep; 261(1):13-23. PubMed ID: 36792178
[TBL] [Abstract][Full Text] [Related]
77. Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers.
Pan Y; Pan Y; Cheng Y; Yang F; Yao Z; Wang O
Cell Biosci; 2018; 8():7. PubMed ID: 29441192
[TBL] [Abstract][Full Text] [Related]
78. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
79. Long non-coding RNA (lncRNA) DSCAM-AS1 is upregulated in breast cancer.
Tarighi M; Khalaj-Kondori M; Hosseinzadeh A; Abtin M
Breast Dis; 2021; 40(2):63-68. PubMed ID: 33554879
[TBL] [Abstract][Full Text] [Related]
80. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
